Skip Navigation

Cardiovascular Research 1997 33(1):131-138; doi:10.1016/S0008-6363(96)00174-5
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Prendergast, B. D
Right arrow Articles by Shah, A. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prendergast, B. D
Right arrow Articles by Shah, A. M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Regulation of left ventricular relaxation in the isolated guinea-pig heart by endogenous endothelin

Bernard D Prendergasta, Peter B Anningb, Malcolm J Lewisb and Ajay M Shaha,*

aCardiovascular Sciences Research Group, Department of Cardiology, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, UK
bCardiovascular Sciences Research Group, Department of Pharmacology, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, UK

Objective: To examine the effects of endogenous endothelin-1 on cardiac contraction in the isolated heart using endothelin receptor antagonists. Methods: Isolated ejecting guinea-pig hearts were perfused with Krebs buffer (1 µM indomethacin) at 37°C, constant loading and heart rate, and high-fidelity left ventricular pressure was monitored by an apical 2F Millar catheter. The effects of the following interventions on left ventricular performance and coronary flow were determined: (a) no treatment (i.e., time controls) (n = 8); (b) the specific ETA receptor antagonist, BQ123 (1 µM, n = 8); (c) the specific ETB receptor antagonist, IRL1038 (0.1 µM, n = 4; 1 µM, n = 6); (d) exogenous endothelin-1 (0.01 nM, n = 6; 0.1 nM, n = 6); (e) the specific ETB receptor agonist, BQ3020 (5 nM, n = 8). Results: All parameters were stable in control (untreated) hearts. BQ123 induced progressive acceleration of early left ventricular pressure decline and a fall in left ventricular end-diastolic pressure with no effect on peak left ventricular pressure, dP/dtmax, stroke volume or coronary flow. IRL1038 had no effect on any of these parameters. In contrast, exogenous endothelin-1 exerted potent vasoconstrictor effects associated with a fall in peak left ventricular pressure, dP/dtmax and stroke volume. Similar changes were observed with BQ3020. Concentrations of endothelin-1 < 0.1 nM, which had no vasoconstrictor effect, produced no change in LV function. Conclusions: These data indicate that basal intracardiac release of endothelin-1 significantly delays LV relaxation in the isolated guinea-pig heart, but has no effect on coronary flow. The contrasting effects of endogenous endothelin-1 (elicited by BQ123) and exogenous endothelin-1 are likely to reflect differences in their site of action and in their effective concentrations at these sites.

KEYWORDS Endothelin-1; Endothelium; Contractile function; Relaxation; Guinea pig; heart


* Corresponding author. Tel.+44 1222 742338; Fax +44 1222 761442; E-mail: shaham2@cf.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Piuhola, I. Szokodi, P. Kinnunen, M. Ilves, R. deChatel, O. Vuolteenaho, and H. Ruskoaho
Endothelin-1 Contributes to the Frank-Starling Response in Hypertrophic Rat Hearts
Hypertension, January 1, 2003; 41(1): 93 - 98.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. MacCarthy, R. Grocott-Mason, B. D. Prendergast, and A. M. Shah
Contrasting Inotropic Effects of Endogenous Endothelin in the Normal and Failing Human Heart : Studies With an Intracoronary ETA Receptor Antagonist
Circulation, January 18, 2000; 101(2): 142 - 147.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Merkus, F. Kajiya, H. Vink, I. Vergroesen, J. Dankelman, M. Goto, and J. A. E. Spaan
Prolonged Diastolic Time Fraction Protects Myocardial Perfusion When Coronary Blood Flow Is Reduced
Circulation, July 6, 1999; 100(1): 75 - 81.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Oie, R. Bjonerheim, H. K. Grogaard, H. Kongshaug, O. A. Smiseth, and H. Attramadal
ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats
Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H868 - H877.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.